We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03233139
Brief Title: Safety and Pharmacokinetics of REGN2810 (Cemiplimab) Anti-programmed Death-ligand 1 (Anti-PD-1) in Japanese Adult Patients With Advanced Malignancies

First Submitted : July 25, 2017
First Submitted that Met QC Criteria : July 25, 2017
First Posted : July 28, 2017

Last Update Submitted that Met QC Criteria : August 29, 2022
Last Update Posted : September 1, 2022